Erasmus University Medical Center Rotterdam competitive analysis

Explore Erasmus University Medical Center Rotterdam's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 27, 2026
Patent NumberPublication DateTitleTotal Oppositions
Mar 22, 2023Soluble "Heavy-Chain Only" Antibodies3
Aug 20, 2014Binding Molecules3

Latest PTAB cases involving Erasmus University Medical Center Rotterdam

Discover the latest PTAB cases involving Erasmus University Medical Center Rotterdam, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Erasmus University Medical Center Rotterdam with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Aug 27, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
ERASMUS UNIVERSITY MEDICAL CENTER ROTTERDAM - 6 - -
ABLYNX158 - -
CRESCENDO BIOLOGICS12 - -
REGENERON PHARMACEUTICALS55148932